Jan 19 (Reuters) - The U.S. health regulator said on Wednesday it was expanding the medical device shortage list to include all blood specimen collection tubes due to supply challenges led by an ...

The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, announced today that its patented upper-arm blood collection device, “LetsGetChecked ImPress,” has been awarded with a ...

Modern blood testing is the foundation of clinical screening and decision-making. Timely disease diagnosis, prevention and chronic care management depend on accurate diagnostic testing. More than 7 ...

Tasso, maker of at-home blood sample collection systems, is launching the next generation of its devices that aim to support patients enrolled in clinical trials and simplify their participation in ...

Babson Diagnostics, an Austin-based diagnostic blood firm, is using a new blood sample collection technology called BetterWay at more than 25 collection sites in the Austin and Temple, Texas, area.

Shortly after securing an FDA clearance last month for its simple, self-operated blood sample collection device, Tasso has teamed up with Catapult Health to help propel its device into people’s homes.

The global blood collection devices market is set to grow from USD 9.13 billion in 2025 to USD 13.02 billion by 2030, with a CAGR of 7.4%. Factors driving market growth include the increasing ...

The plasma proteome is a rich source of potential biomarkers for diseases, such as cancer and neurodegenerative disorders. To assess these proteins, scientists commonly draw whole blood samples into ...

Novel innovations for stabilizing the plasma proteome in whole blood samples provide researchers with more confidence in their protein analysis. To reduce the preanalytical variability, scientists can ...